JP2013536209A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013536209A5 JP2013536209A5 JP2013525178A JP2013525178A JP2013536209A5 JP 2013536209 A5 JP2013536209 A5 JP 2013536209A5 JP 2013525178 A JP2013525178 A JP 2013525178A JP 2013525178 A JP2013525178 A JP 2013525178A JP 2013536209 A5 JP2013536209 A5 JP 2013536209A5
- Authority
- JP
- Japan
- Prior art keywords
- spinal cord
- injury
- syndrome
- stereoisomer
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (8)
- 中枢神経系外傷関連障害の治療において使用するための、化学式(II)
の化合物、または、その薬学的に許容可能な塩、溶媒和物、立体異性体もしくは誘導体であって、
前記誘導体は、化学式(III)
の化合物、または、その薬学的に許容可能な塩、溶媒和物もしくは立体異性体である、
中枢神経系外傷関連障害の治療において使用するための化合物、または、その薬学的に許容可能な塩、溶媒和物、立体異性体もしくは誘導体。 - 前記化合物の前記立体異性体は、RまたはS鏡像異性体である、
請求項1に記載の化合物、または、その薬学的に許容可能な塩、溶媒和物、立体異性体もしくは誘導体。 - 前記中枢神経系外傷関連障害は、完全脊髄損傷、不完全脊髄損傷、脊髄挫傷、脊髄圧迫、脊髄外傷、脊髄損傷、対麻痺、四肢麻痺(quadriplegia)、四肢麻痺(tetraplegia)、脊髄中心部症候群、ブラウン・セカール症候群、脊髄前部症候群、脊髄円錐症候群、馬尾症候群、外傷性脳損傷、TBI、脳損傷、脳ダメージ、頭部外傷、びまん性軸索損傷(DAI)、頭部外傷、脳振盪、脳挫傷、硬膜下血腫、硬膜外血腫、クモ膜下出血、脳内出血、またはCNS圧迫である、
請求項1又は2に記載の化合物、または、その薬学的に許容可能な塩、溶媒和物、立体異性体もしくは誘導体。 - 前記中枢神経系外傷関連障害は、脊髄損傷または脊髄挫傷である、
請求項1又は2に記載の化合物、または、その薬学的に許容可能な塩、溶媒和物、立体異性体もしくは誘導体。 - 中枢神経系外傷関連障害を予防および/または治療するための医薬組成物であって、
治療有効量の請求項1〜4のいずれか1項に記載の化合物、または、その薬学的に許容可能な塩、溶媒和物、立体異性体もしくは誘導体を薬学的な許容可能な媒介物または賦形剤と混合して含む医薬組成物。 - 前記中枢神経系外傷関連障害は、完全脊髄損傷、不完全脊髄損傷、脊髄挫傷、脊髄圧迫、脊髄外傷、脊髄損傷、対麻痺、四肢麻痺(quadriplegia)、四肢麻痺(tetraplegia)、脊髄中心部症候群、ブラウン・セカール症候群、脊髄前部症候群、脊髄円錐症候群、馬尾症候群、外傷性脳損傷、TBI、脳損傷、脳ダメージ、頭部外傷、びまん性軸索損傷(DAI)、頭部外傷、脳振盪、脳挫傷、硬膜下血腫、硬膜外血腫、クモ膜下出血、脳内出血、またはCNS圧迫である、
請求項5に記載の医薬組成物。 - 前記中枢神経系外傷関連障害は、脊髄損傷または脊髄挫傷である、
請求項5に記載の医薬組成物。 - 脊髄損傷または脊髄挫傷を予防および/または治療するための医薬組成物であって、
治療有効量のレフルノミドを薬学的な許容可能な媒介物または賦形剤と混合して含み、第2活性薬剤としての免疫調節性化合物を含まない医薬組成物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37645310P | 2010-08-24 | 2010-08-24 | |
US61/376,453 | 2010-08-24 | ||
EP10008802.0 | 2010-08-24 | ||
EP10008802 | 2010-08-24 | ||
PCT/EP2011/004218 WO2012025217A1 (en) | 2010-08-24 | 2011-08-23 | Novel use of leflunomide and malononitrilamides |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2013536209A JP2013536209A (ja) | 2013-09-19 |
JP2013536209A5 true JP2013536209A5 (ja) | 2014-08-21 |
JP5820476B2 JP5820476B2 (ja) | 2015-11-24 |
Family
ID=44587762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013525178A Active JP5820476B2 (ja) | 2010-08-24 | 2011-08-23 | レフルノミドおよびマロノニトリラマイドの新規の使用 |
Country Status (7)
Country | Link |
---|---|
US (1) | US8957098B2 (ja) |
EP (1) | EP2608782B1 (ja) |
JP (1) | JP5820476B2 (ja) |
CN (1) | CN103153295A (ja) |
DK (1) | DK2608782T3 (ja) |
ES (1) | ES2591355T3 (ja) |
WO (1) | WO2012025217A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE034890T2 (hu) * | 2010-10-29 | 2018-03-28 | Algiax Pharmaceuticals Gmbh | Malononitrilaminok alkalmazása neuropathiás fájdalomban |
EP3928772A1 (en) * | 2020-06-26 | 2021-12-29 | Algiax Pharmaceuticals GmbH | Nanoparticulate composition |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
US5494911A (en) | 1990-05-18 | 1996-02-27 | Hoechst Aktiengesellschaft | Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
EP0607775B1 (de) | 1993-01-08 | 1998-12-09 | Hoechst Aktiengesellschaft | Verwendung von Leflunomid zur Hemmung von Interleukin 1 beta |
US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
US6015557A (en) * | 1999-02-24 | 2000-01-18 | Tobinick; Edward L. | Tumor necrosis factor antagonists for the treatment of neurological disorders |
GB0123571D0 (en) * | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
US6727272B1 (en) | 2002-07-15 | 2004-04-27 | Unitech Pharmaceuticals, Inc. | Leflunomide analogs for treating rheumatoid arthritis |
DK2282778T3 (en) * | 2008-04-29 | 2017-05-01 | Pharnext | NEW THERAPEUTIC APPROACHES TO TREAT ALZHEIMER'S DISEASE AND RELATED DISEASES THROUGH A MODULATION OF ANGIOGENIC |
EP2314291A1 (en) * | 2009-10-22 | 2011-04-27 | Sanofi-Aventis | Use of the combination of teriflunomide and glatiramer acetate for treating multiple sclerosis |
-
2011
- 2011-08-23 JP JP2013525178A patent/JP5820476B2/ja active Active
- 2011-08-23 DK DK11754832.1T patent/DK2608782T3/en active
- 2011-08-23 US US13/817,800 patent/US8957098B2/en active Active
- 2011-08-23 CN CN201180040827XA patent/CN103153295A/zh active Pending
- 2011-08-23 WO PCT/EP2011/004218 patent/WO2012025217A1/en active Application Filing
- 2011-08-23 EP EP11754832.1A patent/EP2608782B1/en active Active
- 2011-08-23 ES ES11754832.1T patent/ES2591355T3/es active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018000858A2 (es) | Derivados de 1,1,1-trifluoro-3-hidroxipropan-2-il carbamato y derivados de 1,1,1-trifluoro-4-hidroxibutan-2-il carbamato como inhibidores de magl | |
JP2017513864A5 (ja) | ||
HRP20200836T1 (hr) | Liječenje bolesti povezanih s imunitetom i upalnih bolesti | |
JP2009510044A5 (ja) | ||
TN2018000121A1 (en) | Valbenazine salts and polymorphs thereof | |
JP2015500223A5 (ja) | ||
RU2019121667A (ru) | Аминопиразолы в качестве селективных ингибиторов янус-киназы | |
JP2014506907A5 (ja) | ||
BR112014029016A2 (pt) | derivados de ácido 7-oxo-tiazolopiridina carbônico e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
JP2012523395A5 (ja) | ||
JP2021105002A5 (ja) | ||
WO2014120808A8 (en) | Pyridone amides as modulators of sodium channels | |
BR112015015477A2 (pt) | derivados de 2,3-di-hidro-isoindol-1-ona e métodos de uso dos mesmos como inibidores de btk | |
EP2279727A3 (en) | Nanoparticulate aripiprazole formulations | |
WO2014078575A3 (en) | Novel orally bioavailable breathing control modulating compounds, and methods of using same | |
PE20211600A1 (es) | 2,3,5-trimetil-6-nonilclohexa-2,5-diena-1,4-diona para suprimir y tratar alfa-sinucleinopatias, tauopatias y otros trastornos | |
WO2012040258A3 (en) | Therapeutic piperazines | |
RU2016131875A (ru) | Производные n-фениллактама, способные стимулировать нейрогенез, и их применение при лечении заболеваний нервной системы | |
JP2016537338A5 (ja) | ||
JP2020534270A5 (ja) | ||
RU2015144483A (ru) | N-(2-цианогетероциклил)пиразолопиридоны в качестве ингибиторов янус-киназы | |
WO2010018996A3 (ko) | 인간 신경줄기세포 및 이를 이용한 중추 또는 말초 신경계 질환 및 손상 치료용 약학적 조성물 | |
BR112014029478A2 (pt) | profármaco de aminoácido contendo flúor | |
JP2013536209A5 (ja) | ||
JP2016515550A5 (ja) |